Explore how machine learning is revolutionising interstitial lung disease management, enhancing early diagnosis, treatment, ...

Exact Sciences drives growth through innovation in cancer detection, with strong products and a promising pipeline. Find out why EXAS stock is a buy.

“It is disturbing to see increased use of fentanyl on the job and in combination with other drugs, given fentanyl’s extreme potency, which can increase risk of impairment, accidents, and potential ...

The Non-Invasive Prenatal Testing (NIPT) market is expected to grow at a moderate CAGR between 2025 and 2032. According to ...

Quest Diagnostics stock has reached an all-time high of $186.38, marking a significant milestone for the $20.75 billion healthcare diagnostics company. According to InvestingPro analysis, the stock ...

Due to Labcorp Holdings’ outperformance relative to the healthcare sector, Wall Street analysts remain strongly optimistic ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

LabConnect is pleased to announce the appointment of Bill Finger as Senior Vice President, Global Strategic Services, ...

Oncosil says a key trial has found its targeted pancreatic cancer radiation treatment to be “safe and feasible to deliver” ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

The United States Drug Abuse Testing Market is projected to grow significantly, reaching US$ 3.71 billion by 2033, up from ...